Five-time Grammy winning musician-singer-songwriter and Boston native James Taylor performed on Dec. 12, 2016, at A Decade of Discovery, a benefit for the Massachusetts General Hospital Cancer Center held at the Museum of Fine Arts.
This gala event was hosted by Jack Connors, Jr., a longtime supporter and benefactor of the Mass General Cancer Center and former chairman of the Partners Healthcare board.
The more than $2.6 million raised at the event will support personalized medicine, early-detection technologies, immunology research efforts and innovative supportive care programs at the Mass General Cancer Center.
Cancer Center Milestones
A Decade of Discovery celebrated the groundbreaking milestones made possible by the Mass General Cancer Center over the last ten years and provided a look into the future of cancer research and care. The program featured past honorees of the one hundred, an awareness and fundraising initiative created and supported by the Mass General Cancer Center. It also highlighted the work of Jay Austen, MD, chief of Plastic and Reconstructive Surgery at Mass General and a 2016 the one hundred honoree, who has pioneered leading-edge techniques that enable breast cancer patients to resume their lives with an improved self-image and renewed confidence.
The event included remarks by Daniel Haber, MD, PhD, director of the Mass General Cancer Center; David Ryan, MD, clinical director of the Mass General Cancer Center; Mr. Connors, Dr. Austen and John Murphy, Mass General patient and 2013 the one hundred honoree.
A Research and Treatment Leader
The Mass General Cancer Center is a pioneer in genetically targeted cancer therapies, as well as diagnostic nanotechnology. The center’s focus on fundamental discovery and its rapid integration into clinical care has led to clinical trials that have set new standards in the treatment of multiple cancers, including lung cancer, breast cancer and melanoma. The Cancer Center is also a pioneer in outcomes research and improving quality of life through supportive care programs.
Building upon this successful track record, the Mass General Cancer Center aims to change the paradigm of cancer treatment: to diagnose and treat cancers early, at a stage where patients are curable through surgery or radiation, combined with genetically-targeted therapy and immunotherapy. The Cancer Center is ideally positioned to shape new standards of care in oncology and share these new approaches with medical institutions throughout the world.
For more information, or to support the Mass General Cancer Center, please contact us.